What Does GenEdit Do?

Total employees54
HeadquartersSouth San Francisco
Founded2016

GenEdit is a privately held biotechnology company focused on developing innovative genetic medicines through its proprietary NanoGalaxy™ platform. This platform utilizes polymer nanoparticles to precisely deliver therapeutic genetic payloads, such as DNA, RNA, and CRISPR-Cas9, to specific tissues and cells. GenEdit aims to overcome the limitations of current viral and lipid-based delivery systems by offering a safer, more targeted, and re-dosable approach for treating a wide range of genetic diseases and cancers.

Where Is GenEdit's Headquarters?

HQ Function

The headquarters serves as the central hub for GenEdit's research and development, corporate operations, strategic partnerships, and administrative functions. It houses state-of-the-art laboratories for polymer chemistry, nanoparticle formulation, and preclinical studies.

Notable Features:

Modern laboratory facilities equipped for advanced gene therapy research, collaborative workspaces designed to foster innovation, and its location within a leading U.S. biotech cluster.

Work Culture:

GenEdit fosters a dynamic, innovative, and science-driven work culture. The environment is collaborative, with a strong emphasis on scientific excellence, problem-solving, and a shared mission to develop impactful therapies for patients.

HQ Significance:

The South San Francisco headquarters is crucial for GenEdit's operations, enabling cutting-edge research and development of its NanoGalaxy™ platform. Its location provides strategic advantages in talent acquisition, industry networking, and access to specialized resources.

Values Reflected in HQ: The headquarters' design and operational focus reflect GenEdit's core values: innovation, scientific rigor, collaboration, urgency, and a commitment to translating scientific discoveries into therapies that can improve patients' lives.

Location:

GenEdit's primary operations, including research and development, are currently centered in the United States. While its physical footprint is concentrated, the company engages with the global scientific community through collaborations, participation in international conferences, and aims for its therapeutic innovations to eventually have a worldwide impact on patient care.

Street Address:

611 Gateway Blvd, Suite 120

City:

South San Francisco

State/Province:

CA

Country:

USA

Where Else Does GenEdit Operate Around the World?

No additional office locations available.

Buying Intent Signals for GenEdit

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading GenEdit? Meet the Executive Team

As of April 2025, GenEdit' leadership includes:

Kunwoo Lee, Ph.D. - Co-founder, President & Chief Executive Officer
Aaron Sato, Ph.D. - Chief Scientific Officer
Romyla Troy, DVM, MS - Chief Development Officer
Aaron Mishel - Chief Financial Officer

Who's Investing in GenEdit?

GenEdit has been backed by several prominent investors over the years, including:

Eli Lilly and Company
Sequoia Capital
Bows Capital
Korea Investment Partners
KDB Investment
Woori Venture Partners
DAYLI Partners
Pathfinder H
DCVC Bio
SK Inc.
Agent Capital
CNSivot

What Leadership Changes Has GenEdit Seen Recently?

Hire1
Exits0

In the past 12 months (mid-2023 to mid-2024), GenEdit significantly bolstered its scientific leadership with the appointment of Dr. Aaron Sato as Chief Scientific Officer. This key hire underscores the company's commitment to advancing its innovative NanoGalaxy™ platform. No major executive departures have been publicly announced during this period.

New Appointments:

Aaron Sato, Ph.D., Dr. Aaron Sato joined GenEdit as Chief Scientific Officer, tasked with spearheading the company's research strategy and advancing its pipeline of genetic medicines.

What Technology (Tech Stack) Is Used byGenEdit?

Discover the tools GenEdit uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

GenEdit Email Formats and Examples

GenEdit likely follows standard corporate email address patterns. The most common format is typically the first initial of the first name followed by the last name.

[first_initial][last]@genedit.com

Format

klee@genedit.com (example for Kunwoo Lee)

Example

75%

Success rate

What's the Latest News About GenEdit?

Business WireNovember 14, 2023

GenEdit Announces $24 Million Series A2 Financing to Advance Novel Polymer Nanoparticles for Systemic Delivery of Genetic Medicines

GenEdit secured $24 million in Series A2 financing. The funding will be used to advance its NanoGalaxy™ platform and pipeline of genetic medicines, focusing on systemic delivery to diverse tissues....more

Business WireJuly 11, 2023

GenEdit Appoints Aaron Sato, Ph.D., as Chief Scientific Officer

GenEdit announced the appointment of Aaron Sato, Ph.D., as its Chief Scientific Officer. Dr. Sato brings extensive experience in drug discovery and development to lead GenEdit's research initiatives....more

GlobeNewswireMay 18, 2023

GenEdit Presents Preclinical Data Demonstrating Potent and Durable Gene Editing in the Central Nervous System with its NanoGalaxy™ Polymer Nanoparticles at ASGCT 2023

GenEdit presented promising preclinical data at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting, showcasing the potential of its NanoGalaxy™ platform for delivering gene editing therapies to the central nervous system....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including GenEdit, are just a search away.